miR‑421 promotes the viability of A549 lung cancer cells by targeting forkhead box O1
- Xiao-Mei Mo
- Peng-Fei Qin
- Bing Wang
- Feng-Hai Liu
- Hua-Hui Li
Affiliations: Pharmacy Department, Qingdao Women and Children's Hospital, Qingdao University, Qingdao, Shandong 266034, P.R. China, Department of Laboratory Medicine, Qingdao Municipal Hospital, Qingdao, Shandong 266071, P.R. China
- Published online on: September 29, 2020 https://doi.org/10.3892/ol.2020.12169
Copyright: © Mo
et al. This is an open access article distributed under the
terms of Creative
Commons Attribution License.
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
MicroRNA (miR)‑421 has been reported to serve various important roles in numerous types of cancer, including neuroblastoma and gastric cancer. However, to the best of our knowledge, few reports have determined the role of miR‑421 in lung cancer. The aim of the current study was to analyze the expression levels of miR‑421 in A549 lung cancer cells, to determine the target gene of miR‑421, and to investigate the function and mechanism of miR‑421 in cellular cytotoxicity. miR‑421 expression levels were analyzed in A549 lung cancer cells using reverse transcription‑quantitative PCR, a MTT assay was performed to determine the effect of miR‑421 on A549 cell cytotoxicity and the protein expression levels of forkhead box O1 (FOXO1) were determined via western blotting. The target gene of miR‑421 was predicted and verified using TargetScan and a dual‑luciferase reporter assay, respectively. The results revealed that miR‑421 expression levels were significantly upregulated in A549 lung cancer cell lines compared with the normal cells (P<0.01). Additionally, it was discovered that miR‑421 promoted A549 cell viability (P<0.01) compared with A549 transfected with negative control. miR‑421 was also identified to bind to the 3'‑untranslated region of FOXO1. In A549 cells transfected with miR‑421‑mimics, the expression levels of phosphorylated (p)‑AKT, p‑glycogen synthase kinase‑3β, p‑retinoblastoma and cyclin D1 were significantly upregulated (P<0.01), whereas the expression levels of FOXO1 and p21 were significantly downregulated (P<0.01) compared with the control group. In conclusion, the results of the present study suggested that miR‑421 may promote the viability of A549 lung cancer cells by targeting FOXO1 and modulating cell cycle, indicating that targeting miR‑421 and FOXO1 may represent future therapeutic strategies for the treatment of patients with lung cancer.